Nanmu Yang

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Corrigendum to "CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma" [Cancer Lett. 614 (2025) 217473].

Corrigendum to "CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma" [Cancer Lett. 614 (2025) 217473].

Journal: Cancer letters

Published: May 11, 2025

Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma.

Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma.

Journal: Cancer medicine

Published: January 14, 2025

SAE1 emerges as a pan-cancer driver and key regulator of HCC metastasis.

SAE1 emerges as a pan-cancer driver and key regulator of HCC metastasis.

Journal: Journal of advanced research

Published: September 29, 2024

CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma.

CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma.

Journal: Cancer letters

Published: September 24, 2024

CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.

CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.

Journal: Cancer letters

Published: December 12, 2023

Duodenal ampulla neuroendocrine tumor and gastrointestinal stromal tumors in a case of neurofibromatosis type 1: a case report.

Duodenal ampulla neuroendocrine tumor and gastrointestinal stromal tumors in a case of neurofibromatosis type 1: a case report.

Journal: Frontiers in oncology

Published: November 10, 2023

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis.

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis.

Journal: Journal of hepatocellular carcinoma

Published: June 06, 2023

Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.

Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.

Journal: Cancer cell

Published: January 12, 2023

HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.

HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.

Journal: Journal of cellular physiology

Published: June 30, 2020

miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma.

miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma.

Journal: Cancer cell international

Published: June 06, 2018

Expressions of stem cell factor and hypoxia inducible factor 1 alpha in pancreatic cancer cells and related mechanism

Expressions of stem cell factor and hypoxia inducible factor 1 alpha in pancreatic cancer cells and related mechanism

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: July 18, 2017

Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling.

Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling.

Journal: Oncology letters

Published: December 09, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026